Turenne Santé
9 rue de Téhéran, Paris, Ile-de-France, 75008, France
Overview
Turenne Capital is an independant private equity management company, with 4 offices in France : - Paris - Lyon - Marseilles - Lille (joint-venture). Since 1999, Turenne Capital has been taking significant minority or majority equity stakes alongside entrepreneurs who operate SMEs with revenues ranging from €5 million to € 100 million. It invests between €1 million and €10 million per transaction. Turenne Capital manages/advises more than € 500 million. 32 people, among which 21 investors work in the Group. ------------------------------------------------------------------------------ Turenne Capital est une Société de gestion indépendante spécialisée en capital investissement. Turenne Capital accompagne depuis 1999 des entrepreneurs dans leur développement et la transmission de leur société et est implantée à : - Paris - Lyon - Marseille - Lille (filiale) Les tickets d'investissement vont de '1 à 10 millions d'euros en minoritaire et majoritaire dans des PME de 5 à 100 M€ de Chiffre d'affaires. Le Groupe Turenne Capital compte 32 professionnels dont 21 investisseurs, et gère/conseille plus de 500 M€ confiés par des institutionnels et des particuliers.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 8
Sector focus
- Outsourcing
- Venture Capital
- Video Games
Investment portfolio
- Kimialys
Led · Series A · Dec 2025
Founded in 2020, Kimialys has created and commercializes an innovative chemistry-based platform that functionalizes surfaces such as nanoparticles, biopuces and electrodes for in-vitro diagnostic and analytical applications. By improving surface treatment, the company aims to boost the sensitivity and reliability of diagnostic tests. The newly raised capital will enable Kimialys to finalize the industrialization of its processes and scale up production capacity. It also plans to launch an initial catalog of ready-to-use kits, broadening its product offering. A portion of the funds will be directed toward intensifying international commercial efforts. Although specific revenue or user metrics are not disclosed, the Series A round indicates investor confidence in the company’s commercialization and growth trajectory.